Clair, a startup founded by Stanford graduates, is developing a wearable hormone-tracking device to improve how women access and understand their hormonal health. The company, started by Jenny Duan ...
Irvine-based Masimo, which was acquired by Danaher, has received FDA clearance for a monitor feature to detect opioid-induced ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
A major challenge in continuous fetal monitoring is that both the fetus and the umbilical cord are constantly moving. To address this, the researchers developed autonomous tracking algorithms that ...
On the earnings call in August, new CEO Katie Szyman, who joined Masimo in February from BD, sought to reassure investors that the company’s decades-long relationship with Philips remained strong.
However, A1C isn’t your only option for tracking your blood sugar levels: Continuous glucose monitors (CGMs) have moved beyond type 1 diabetes care to being an important tool for type 2 management as ...
is a senior reporter and author of the Optimizer newsletter. She has more than 13 years of experience reporting on wearables, health tech, and more. Before coming to The Verge, she worked for Gizmodo ...
Continuous glucose monitoring (CGM) is no longer limited to type 1 diabetes (T1D) and may play a significant role in shaping the care of type 2 diabetes (T2D). Emerging evidence indicates that broader ...
NYSE:MS: $24.27 million (15.6% of AUM) NASDAQ:AMZN: $15.30 million (9.8% of AUM) NYSE:TEVA: $11.47 million (7.4% of AUM) NYSE:NKE: $11.45 million (7.4% of AUM) NYSE:ALC: $8.53 million (5.5% of AUM) As ...
Irvine-based health technology and consumer electronics firm Masimo Corp. announced it entered into a definitive agreement to be acquired by healthcare company Danaher Corporation (Danaher). Under the ...
Forbes contributors publish independent expert analyses and insights. Founder & Advisor on Emerging Tech. Covering VC. This voice experience is generated by AI. Learn more. This voice experience is ...
Global life sciences giant Danaher coughed up a pretty penny to buy Masimo this week, spending roughly $10 billion to beef up its diagnostics portfolio. The deal values medical device developer Masimo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results